References
- Kino T., Hatanabe H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., Imanaka H. FK506, a novel immunosuppressant isolated from a streptomyces: I. Fermentation, isolation, and physio-chemical and biological characteristics. J. Antibiotics 1987; 40: 1249–1255
- Kino T., Hatanabe H., Miyato S., Inamura N., Nishiyama M., Yajima T., Goto T., Okuhara M., Kohsaka M., Aoki H., Ochiai T. FK506, a novel immunosuppressant isolated from a streptomyces: II. Immunosuppressive effect of FK506 in vitro. J Antibiotics 1987; 40: 1256–1265
- Sawada S., Suzuki G., Kawase Y., Takaku F. Novel immunosuppressive agent, FK506: In vitro effects on the cloned T cell activation. J. Immunol. 1987; 139: 1797–1803
- Tocci M. J., Matkovich D. A., Collier K. A., Kwok P., Dumont F., Lin S., Degudicibus S., Siekierka J. J., Chin J., Hutchinson N. I. The immuno-suppressant FK506 selectively inhibits expression of early T cell activation genes. J. Immunol. 1989; 143: 718–726
- Ochiai T., Nagata M., Nakajima K., Sakamoto K., Asano T., Isono K. Prolongation of canine renal allograft survival by treatment with FK506. Transplant. Proc. 1987; 19: 53–56
- Collier St. D. J., Thiru S., Calne R. Kidney transplantation in the dog receiving FK506. Transplant. Proc. 1987; 19: 62–70
- Kawashima H., Fujino Y., Mochizuki M. Effects of a new immunosupressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 1988; 29: 1265–1271
- Mochizuki M., Kawashima H. Effects of FK506, 15-deoxyspergualin, and cyclosporine on experimental autoimmune uveoretinitis in the rat. Autoimmunity 1990; 8: 37–41
- Ni M., Chan C. C., Nussenblatt R. B., Mochizuki M. FR900506(FK506) and 15-deoxysper-gualin (15-DSG) modulate the kinetics of infiltrating cells in eyes with experimental autoimmune uveo-retinitis. Autoimmunity 1990; 8: 43–51
- Kawashima H., Mochizuki M. Effects of a new immunosuppressive agent, FK506, on the efferent limb of the immune responses. Exp. Eye Res. 1990; 51: 565–572
- Kawashima H., Fujino Y., Mochizuki M. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat. Invest. Ophthalmol. Vis. Sci. 1990; 31: 2500–2507
- Fujino Y., Mochizuki M., Chan C. C., Raber J., Kotake S., Gery I., Nussenblatt R. B. FK506 treatment of S-antigen induced uveitis in primates. Curr. Eye Res. 1991; 10: 679–690
- Shapiro R., Fung J. J., Jain A. B., Parks P., Todo S., Starzl T. E. The side effects of FK506 in humans. Transplant. Proc. 1990; 22: 35–36
- Guide for Care and Use of Laboratory Animals. DRR/NIH, Bethesda, MDUSA, 202–05, DHEW Publication No. (NIH) 80–23. Revised 1978, reprinted 1980. Office of Science and Health Reports
- Fujino Y., Kawashima H., Okumura A., Mochizuki M. Purification and uveogenicity of retinal antigens. Acta. Soc. Ophthalmol. Jpn. 1987; 91: 498–508
- Mochizuki M., Nussenblatt R. B., Kuwabara T., Gery I. Effects of cyclosporine and other immunosupressive drugs on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 1985; 26: 226–232
- BenEzra D., Forrester F. V., Nussenblatt R. B., Tabbara K., Timonen P. Uveitis scoring system. Uveitis Scoring System, D. BenEzra, F. V. Forrester, R. B. Nussenblatt, K. Tabbara, P. Timonen. Springer-Verlag, Berlin 1991; 1–13
- Mochizuki M. A multi-center clinical open trial of FK506 in refractory uveitis including Behcet's disease. Transplant. Proc. 1991, for Japanese FK506 Study Group on Refractory Uveitis. (in press)
- Todo S., Fung J. J., Demetris A. J., Jain A., Venkataramanan R., Starzl T. E. Early trial with FK506 as primary treatment in liver transplantation. Transplant. Proc. 1990; 22: 13–18
- Mc Canley J., Fung J., Jain A., Todo S., Starzl T. E. The effects of FK506 on renal function after liver transplantation. Transplant. Proc. 1990; 22: 17–20